1. Taieb C, Macy G, Sibaud V, et al. Hair loss: an epidemiologic approach. J Am Acad Dermatol 2008; 58: AB82.
2.
Jamerson TA, Aguh C. An approach to patients with alopecia. Med Clin North Am 2021; 105: 599-610.
3.
Vañó-Galván S, Saceda-Corralo D, Blume-Peytavi U, et al. Frequency of the types of alopecia at twenty-two specialist hair clinics: a multicenter study. Skin Appendage Disord 2019; 5: 309-15.
4.
Dhami L. Psychology of hair loss patients and importance of counseling. Indian J Plast Surg 2021; 54: 411-5.
5.
Zucchelli F, Mathews A, Sharratt N, et al. The psychosocial impact of alopecia in men: a mixed-methods survey study. Skin Health Dis 2024; 4: e420.
6.
Katoulis AC, Christodoulou C, Liakou AI, et al. Quality of life and psychosocial impact of scarring and non-scarring alopecia in women. J Dtsch Dermatol Ges 2015; 13: 137-42.
7.
Gupta S, Goyal I, Mahendra A. Quality of life assessment in patients with androgenetic alopecia. Int J Trichol 2019; 11: 147-52.
8.
Finlay AY, Khan GK. Dermatology Life Quality Index (DLQI): a simple practical measure for routine clinical use. Clin Exp Dermatol 1994; 19: 210-6.
9.
Abedini R, Hallaji Z, Lajevardi V, et al. Quality of life in mild and severe alopecia areata patients. Int J Women's Dermatol 2018; 4: 91-4.
10.
Chularojanamontri L, Sethabutra P, Kulthanan K, et al. Dermatology life quality index in Thai patients with systemic sclerosis: a cross-sectional study. Indian J Dermatol Venereol Leprol 2011; 77: 683-7.
11.
Basu S, Poole J. The Brief Illness Perception Questionnaire. Occup Med 2016; 66: 419-20.
12.
Gosak L, Stiglic G. Cognitive and emotional perceptions of illness in patients diagnosed with type 2 diabetes mellitus. Healthcare 2024; 12: 199.
13.
Fereidouni M, Rezapour H, Saharkhiz M, et al. A study of the association of cognitive abilities and emotional function with allergic disorders in young women. BMC Womens Health 2021; 21: 205.
14.
Tran TD, Tran T, Fisher J. Validation of the depression anxiety stress scales (DASS) 21 as a screening instrument for depression and anxiety in a rural community-based cohort of northern Vietnamese women. BMC Psychiatry 2013; 13: 24.
15.
Nasimi M, Ahangari N, Lajevardi V, et al. Quality of life and mental health status in patients with lichen planopilaris based on Dermatology Life Quality Index and General Health Questionnaire-28 questionnaires. Int J Womens Dermatol 2020; 6: 399-403.
16.
Kelati A, Jafferany M. Quality-of-life assessment and the impact of early diagnosis and treatment in lichen planopilaris: a systematic review. Clin Exp Dermatol 2024; 50: 146-9.
17.
Chiang YZ, Bundy C, Griffiths CEM, et al. The role of beliefs: lessons from a pilot study on illness perception, psychological distress and quality of life in patients with primary cicatricial alopecia. Br J Dermatol 2015; 172: 130-7.
18.
Saceda-Corralo D, Pindado-Ortega C, Moreno-Arrones ÓM, et al. Health-related quality of life in patients with frontal fibrosing alopecia. JAMA Dermatol 2018; 154: 479-80.
19.
Alirezaei P, Ahmadpanah M, Rezanejad A, et al. Compared to controls, individuals with lichen planopilaris have more depression, a lower self-esteem, and a lower quality of life. Neuropsychobiology 2019; 78: 95-103.
20.
Doche I, Romiti R, Rivitti-Machado MC, et al. Quality-of-life impairment is not related to disease activity in lichen planopilaris and frontal fibrosing alopecia. Results of a preliminary cross-sectional study. J Eur Acad Dermatol Venereol 2022; 36: e288-90.
21.
Varghaei A, Rostami A, Yarmohamadi M, et al. Assessment of health-related quality of life in patients with frontal fibrosing alopecia. J Cosmet Dermatol 2022; 21: 6169-73.